NCT00501696View on ClinicalTrials.gov

A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Multiple Sclerosis
Interventions
DRUG

4.5 mg Naltrexone

low dose naltrexone 4,5mg on the multiple sclerosis quality of life inventory (MSQLI54)

DRUG

Naltrexone

4,5mg low dose naltrexone on the multiple sclerosis quality of life inventory (MSQLI54)

Trial Locations (1)

94117

MS Center UCSF, Parnassus Ave, suite #908, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00501696 - A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone | Biotech Hunter | Biotech Hunter